Suppr超能文献

采用大豆凝集素和绵羊红细胞对与 HLA - A、B、D、DR 不相容的亲代骨髓细胞进行分离后,用于重症联合免疫缺陷的移植。

Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.

作者信息

Reisner Y, Kapoor N, Kirkpatrick D, Pollack M S, Cunningham-Rundles S, Dupont B, Hodes M Z, Good R A, O'Reilly R J

出版信息

Blood. 1983 Feb;61(2):341-8.

PMID:6217853
Abstract

Three patients with severe combined immunodeficiency (SCID) received transplants of HLA haplotype-mismatched parental bone marrow depleted of T lymphocytes by differential agglutination with soybean agglutinin (SBA) and subsequent E-rosette depletion. Two patients achieved durable engraftment with reconstitution of both humoral and cell-mediated immunity. Neither of these patients developed graft versus host disease (GVHD). The third patient achieved only a transient engraftment with concomitant development of mitogen-responsive lymphocytes of paternal origin. Our experience indicates that depletion of T lymphocytes by this technique can abrogate the potential of histoincompatible marrow grafts to induce lethal GVHD without limiting immunologic reconstitution. It also provides further evidence of nonimmune mechanisms of graft resistance that may necessitate preparative treatment of patients with SCID before transplantation with HLA-mismatched marrow cells.

摘要

三名重症联合免疫缺陷(SCID)患者接受了通过大豆凝集素(SBA)差异凝集及随后的E花环去除法去除T淋巴细胞的HLA单倍型不匹配的亲代骨髓移植。两名患者实现了持久植入,体液免疫和细胞介导免疫均得以重建。这两名患者均未发生移植物抗宿主病(GVHD)。第三名患者仅实现了短暂植入,同时出现了父源有丝分裂原反应性淋巴细胞。我们的经验表明,通过该技术去除T淋巴细胞可以消除组织不相容骨髓移植物诱导致命性GVHD的可能性,而不限制免疫重建。这也进一步证明了移植物抗性的非免疫机制,这可能需要在对SCID患者进行HLA不匹配骨髓细胞移植前进行预处理。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验